Italy unlocks handcuffs on Novartis' vaccines

The leader of the pack has come around on Novartis' ($NVS) flu vaccines. The company said authorities in Italy have lifted a ban on a number of Novartis vaccines there. Italy had imposed the bans two weeks ago after the company informed authorities that it had pulled one batch of the vaccine because it contained elevated protein aggregates. The vaccine is made at a plant in Siena, Italy. Article

Suggested Articles

Solid Bio fixed the manufacturing issue that led to a partial clinical hold on its DMD trial, but a full hold remains.

Commissioner Scott Gottlieb has laid out the reasons why he thinks the FDA needs a double-digit budget bump.

GW's cannabis-based epilepsy drug scored a favorable review from FDA staff ahead of an expert panel meeting.